Inflammatory neuropathies represent a wide spectrum of disorders with important differences in immunologic mechanisms Effective treatment and accurate prognosis is based on accurate diagnosis from clinical laboratory and electredugnostic data. Selection of treatment options should be guided by evidence-based data (randomized controlled trials)- In this article we review the treatment of the various forms of Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy and data supporting each modality.